FDA Inspection
Guardian Drug Co. Inc.Guardian Drug Co. Inc. – FDA Inspection, Nov 6, 2017
Record Details
This FDA Inspection record concerns Guardian Drug Co. Inc., with an inspection on November 6, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 196cb87f-69a9-4569-8ae0-addd036aa3e0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1030766
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Guardian Drug Co. Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2026 | Not classified | New Jersey District Office | |
| November 7, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2016 | Not classified | New Jersey District Office | |
| August 15, 2014 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for Guardian Drug Co. Inc.
- FDA Inspection 1304382 - 2026-01-16
- FDA Inspection 1231141 - 2024-11-07
- FDA Inspection 1162476 - 2022-02-17
- FDA Inspection 996009 - 2016-12-06
- FDA Inspection 890734 - 2014-08-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.